AQR-Capital-Management

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
13,314
Total Value
97069812583
Accession Number
0001085146-25-003311
Form Type
13F-HR
Manager Name
AQR-Capital-Management
Data Enrichment
96% identified
12,822 identified492 unidentified

Holdings

13,314 positions • $97.1B total value
Manager:
Search and click to pin securities to the top
Page 148 of 158
CRAWFORD & CO
Shares:13.1K
Value:$150.0K
% of Portfolio:0.0% ($150.0K/$97.1B)
Taysha Gene Therapies, Inc.
Shares:107.9K
Value:$150.0K
% of Portfolio:0.0% ($150.0K/$97.1B)
PUMA BIOTECHNOLOGY, INC.
Shares:50.5K
Value:$149.4K
% of Portfolio:0.0% ($149.4K/$97.1B)
LINDBLAD EXPEDITIONS HOLDINGS, INC.
Shares:16.0K
Value:$148.3K
% of Portfolio:0.0% ($148.3K/$97.1B)
Adverum Biotechnologies, Inc.
Shares:33.8K
Value:$147.8K
% of Portfolio:0.0% ($147.8K/$97.1B)
Aeva Technologies, Inc.
Shares:20.8K
Value:$145.9K
% of Portfolio:0.0% ($145.9K/$97.1B)
FIRST ADVANTAGE CORP
Shares:10.4K
Value:$145.9K
% of Portfolio:0.0% ($145.9K/$97.1B)
PureCycle Technologies, Inc.
Shares:21.0K
Value:$145.1K
% of Portfolio:0.0% ($145.1K/$97.1B)
NI Holdings, Inc.
Shares:10.0K
Value:$143.1K
% of Portfolio:0.0% ($143.1K/$97.1B)
Pulmonx Corp
Shares:21.2K
Value:$142.6K
% of Portfolio:0.0% ($142.6K/$97.1B)
Aveanna Healthcare Holdings, Inc.
Shares:26.3K
Value:$142.4K
% of Portfolio:0.0% ($142.4K/$97.1B)
Annexon, Inc.
Shares:73.8K
Value:$142.4K
% of Portfolio:0.0% ($142.4K/$97.1B)
ARS Pharmaceuticals, Inc.
Shares:11.1K
Value:$139.8K
% of Portfolio:0.0% ($139.8K/$97.1B)
TEMPLETON EMERGING MARKETS FUND
Shares:10.9K
Value:$139.6K
% of Portfolio:0.0% ($139.6K/$97.1B)
Absci Corp
Shares:55.5K
Value:$139.4K
% of Portfolio:0.0% ($139.4K/$97.1B)
Nurix Therapeutics, Inc.
Shares:11.7K
Value:$138.6K
% of Portfolio:0.0% ($138.6K/$97.1B)
Kyverna Therapeutics, Inc.
Shares:71.1K
Value:$137.1K
% of Portfolio:0.0% ($137.1K/$97.1B)
02217A102
Shares:27.2K
Value:$134.5K
% of Portfolio:0.0% ($134.5K/$97.1B)
Ramaco Resources, Inc.
Shares:16.3K
Value:$134.5K
% of Portfolio:0.0% ($134.5K/$97.1B)
ImmunityBio, Inc.
Shares:44.4K
Value:$133.8K
% of Portfolio:0.0% ($133.8K/$97.1B)